Metraipolis › archive › dc_ea1f78becbf0

Stereotactic radiotherapy for brain metastases: indications, dose fractionation, technological innovations, and evolving combination strategies - a… — Europe PMC PMID:42109678

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42109678
DOI: 10.3389/fonc.2026.1821752
License (as archived): solo-consultazione
Archived: 2026-11-03T06:41:35.364Z
SHA-256 of the archived text: 42c510db32da50e20f0bcfd49a9fadc6d07210df5f6372099c3f895149a95b75
Stable URL of this page: https://metraipolis.com/documento/dc_ea1f78becbf0

How to cite

Stereotactic radiotherapy for brain metastases: indications, dose fractionation, technological innovations, and evolving combination strategies - a… — Europe PMC PMID:42109678 — Europe PMC (en), https://europepmc.org/article/MED/42109678 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea1f78becbf0 (Metraipolis archive dc_ea1f78becbf0, sha256 42c510db32da50e20f0bcfd49a9fadc6d07210df5f6372099c3f895149a95b75)

BibTeX

@misc{dcea1f78becbf0,
  title = {Stereotactic radiotherapy for brain metastases: indications, dose fractionation, technological innovations, and evolving combination strategies - a… — Europe PMC PMID:42109678},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42109678},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea1f78becbf0; sha256 42c510db32da50e20f0bcfd49a9fadc6d07210df5f6372099c3f895149a95b75},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42109678. Agents can read the archived copy with the MCP tool read_document.